SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,180,209.38070502. The last known price of Ethereum is 2,270.17304981 USD and is up 0.59 over the last 24 hours. It is currently trading on 14230 active market(s) with $5,193,092,001.43 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention amid a broad crypto selloff linked to the reported record-scale Binance hack, which has stirred concerns about exchange security and possible further selling. Traders are divided between viewing the dip as a buying opportunity and warning that trust concerns and market weakness could bring more downside.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs scheduled quarterly report is the main focus, with traders debating whether guidance can justify its high valuation amid a broader pullback in AI stocks. Bulls expect continued AI-driven growth, while bears argue that even an earnings beat may disappoint if the outlook does not exceed already high expectations.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp QQQ pullback has sparked debate over whether weak Big Tech earnings and concerns about AI spending and returns signal deeper tech weakness or an oversold dip-buying opportunity. Traders are also watching oil and Iran-talk headlines as potential drivers of a rebound, but the outlook remains divided.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Reports that Marvell is in advanced talks to acquire Lumentum have fueled heavy selling and debate over the potential deals cost and financing, particularly shareholder dilution and added debt; the talks remain unconfirmed. Traders are split between seeing the move as a costly risk for shareholders and a strategic way to secure optical components for AI data centers, against a broader weak tape for tech stocks.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY discussion centers on a sharp selloff followed by a volatile rebound, which traders associate with falling oil and hopes for U.S.-Iran de-escalation ahead of midterms. Bulls are buying the dip and anticipating more gains, while skeptics call the bounce a trap and point to AI-related tech weakness and lingering geopolitical uncertainty.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

A sharp semiconductor selloff is fueling debate after weak Intel guidance and concerns that heavy AI infrastructure spending may not generate returns fast enough. Bears see a broader AI-trade unwind and deleveraging, while bulls argue that continuing chip demand and hyperscaler investment support a recovery; traders are also watching key support levels.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios accelerated FDA approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS and triggered a sharp selloff. Traders debate the threat: some emphasize Inovios potential to reduce surgeries, while others point to Precigens first-mover commercial lead and full approval, alongside questions about the rivals launch and reimbursement path.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

ANET is drawing attention after a sharp pullback from recent highs, with traders pointing to selling pressure and technical weakness ahead of the next earnings report; some also cite bearish options flow and insider sales, though these are not established as the cause. The community is split between treating the decline as a buying opportunity based on Aristas AI data-center networking demand and cash-rich balance sheet, and waiting for further downside or support to form.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels sharply weaker-than-expected outlook after its quarterly reportamid soft PC demand and supply constraintstriggered a historic selloff and renewed concerns about its recovery and exposure to the AI trade. Traders are split between calling the drop an overreaction and buying the dip, and warning that further losses may follow.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks stronger-than-expected third-quarter results and raised full-year outlook are drawing attention, with traders also highlighting a bullish flag pattern and a potential breakout. Some discussion continues around the melanoma cancer-vaccine partnership with Moderna, but views differ on how much commercial value the trial results may add.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
